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Abstract 
Objective: Glycaemic Index (GI) ranks the body’s response to carbohydrate content in food such that high GI food 
increases postprandial blood glucose levels. One of the popular drinks at food and beverage outlets is a drink made 
from calamansi, a citrus that is believed not to induce an increase in blood glucose levels. In this non-randomised 
single-blind (participants) study, capillary blood from 10 healthy males were sampled following consumption of either 
glucose or the calamansi drink. The blood glucose measurements were then used to calculate the GI for the drink.
Results: The GI of the calamansi drink tested was calculated as 37, a value within the range of low GI foods.
Trial registration Clinical Trials identifier NCT04462016; Retrospectively registered on July 1, 2020.
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Introduction
Diabetes mellitus is becoming a major public health con-
cern worldwide [1]. Prolonged hyperglycaemia increases 
the risk of microvascular damage such as neuropathy 
that contributes to increased macrovascular complica-
tions such as ischaemic heart disease and ultimately 
reduced life expectancy [2]. As diabetics have increased 
hunger and food intake partly due to accelerated gastric 
emptying caused by absent or delayed secretion of insu-
lin [3], normalising blood glucose slows its progression 
and prevents the development of complications [4]. Low 
glycaemic index (GI) food with a GI of 55 or lower, are 
slowly absorbed and produces lower peaks in blood glu-
cose, which is useful for maintaining glycaemic control 
[5]. Decreased rate of glucose absorption reduces post-
prandial rise in gut hormones such as incretins and insu-
lin by maintaining suppression on free fatty acids (FFA) 
and counter regulatory responses, while at the same time 
achieving lower blood glucose concentrations. Over time, 
glucose is withdrawn from the circulation at a faster rate 
such that its levels return to baseline despite continued 
absorption from the gut [6].
Calamansi, which is also known as “calamondin” in 
America or “limau kasturi” in Malaysia [7], is consumed 
by many due to its potential health benefits [8] that 
includes the potential to lower post-prandial blood glu-
cose [9]. Blood glucose response following consumption 
of a commercially sold calamansi drink was evaluated in 
this study. Data from this study will be helpful to con-
sumers making drink choices in view of the increasing 
number diabetic individuals in the community [10]. Data 
from this study will also provide baseline information for 




This non-randomised, single-blind (participants) study 
that was based on the report of a joint consultation 
between the Food and Agriculture Organization (FAO) 
and World Health Organisation (WHO) [11] was con-
ducted between January and May of 2018 at the teach-
ing laboratory of the Faculty of Medicine and Health 
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